AI/ML Innovations Inc. Announces Shares for Debt Transaction
AI/ML Innovations Inc. Announces Shares for Debt Transaction
VICTORIA, BC / ACCESSWIRE / June 14, 2024 / AI/ML Innovations Inc. (the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) announced that it has entered into a shares for debt transaction with Wonderful Ventures LLC of Las Vegas, Nevada ("WV"). The Company entered into a finder's agreement dated June 7, 2024 with WV wherein WV would assist the Company in the search for a new CEO. Pursuant to the terms of the Finder's Agreement, the Company will pay CAD $67,600 to WV by a cash payment of $30,000 and the issuance of C$37,600 in Common Shares of the Company (the "Shares for Debt Transaction"). Pursuant to the Shares for Debt Transaction, the Company will issue an aggregate of 750,000 Common Shares, at a deemed price of $0.05 per Common Share. The proposed Shares for Debt Transaction is subject to the approval of the Canadian Securities Exchange.
不列顛哥倫比亞省維多利亞州/ACCESSWIRE/2024年6月14日/AI/ML Innovations Inc.（“公司”）（CSE: AIML）（OTCQB: AIMLF）（FWB: 42FB）宣佈已與內華達州拉斯維加斯的Wonderful Ventures LLC（“WV”）簽訂股票進行債務交易。該公司於2024年6月7日與西弗吉尼亞州簽訂了發現者協議，根據該協議，西弗吉尼亞將協助公司尋找新的首席執行官。根據發現者協議的條款，公司將通過現金支付30,000美元和發行37,600加元的公司普通股（“債務交易股份”）向西弗吉尼亞州支付67,600加元。根據債務交易股份，公司將共發行75萬股普通股，認定價格爲每股普通股0.05美元。擬議的債務交易股份有待加拿大證券交易所的批准。
The Common Shares issued will be subject to a four-month hold period.
發行的普通股將有四個月的持有期。
About AI/ML Innovations Inc.
關於 AI/ML Innovations Inc
AI/ML Innovations Inc. has realigned its business operations to capitalize on the burgeoning fields of artificial intelligence (AI) and machine learning (ML), with an initial investment focus on emerging digital health and wellbeing companies that leverage AI, ML, cloud computing and digital platforms to drive transformative healthcare management solutions and precision support delivery across the health continuum. Through strategic partnerships with Health Gauge (95.2% owned by AIML), Tech2Heal (up to 22% ownership rights, with 12.44% currently owned by AIML), AI Rx Inc. (70% owned by AIML) and other planned accretive investments, the Company continues to capitalize on expanding growth areas, to the benefit of all the Company's stakeholders. AI/ML's shares are traded on the Canadian Securities Exchange under the symbol "AIML", the OTCQB Venture Market under "AIMLF", and the Frankfurt Stock Exchange under "42FB".
AI/ML Innovations Inc.調整了其業務運營，以利用新興的人工智能（AI）和機器學習（ML）領域，最初的投資重點是新興的數字健康和福祉公司，這些公司利用人工智能、機器學習、雲計算和數字平台推動變革性的醫療管理解決方案和整個健康連續體的精準支持交付。通過與Health Gauge（AIML持有95.2％的股權）、Tech2Heal（高達22％的所有權，目前由AIML持有12.44％的所有權）、AI Rx Inc.（AIML持有70％的股權）以及其他計劃中的增值投資，公司繼續利用不斷擴大的增長領域，使公司所有利益相關者受益。AI/ML的股票在加拿大證券交易所交易，代碼爲 “AIML”，OTCQB風險投資市場以 “AIMLF” 的形式交易，在法蘭克福證券交易所交易的代碼爲 “42FB”。
On behalf of the Board of Directors
Tim Daniels, Executive Chairman
代表董事會
蒂姆·丹尼爾斯，執行主席
For more information about AI/ML Innovations:
有關 AI/ML 創新的更多信息:
For detailed information please see AI/ML's website or the Company's filed documents at .
For further information, contact: Blake Fallis at (778) 405-0882 or info@aiml-innovations.com.
有關詳細信息，請參閱AI/ML的網站或公司提交的文件，網址爲。
欲了解更多信息，請致電 (778) 405-0882 或 info@aiml-innovations.com 與 Blake Fallis 聯繫。
THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER TO SELL OR THE SOLICITATION OF AN OFFER TO BUY ANY SECURITIES IN ANY JURISDICTION, NOR SHALL THERE BE ANY OFFER, SALE, OR SOLICITATION OF SECURITIES IN ANY STATE IN THE UNITED STATES IN WHICH SUCH OFFER, SALE, OR SOLICITATION WOULD BE UNLAWFUL.
本新聞稿不構成任何司法管轄區的賣出要約或購買任何證券要約的邀請，在美國任何州，也不存在任何此類要約、出售或招攬爲非法的證券要約、出售或招標。
Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE)
accepts responsibility for the adequacy or accuracy of this release.
既不是CSE也不是其監管服務提供商（該術語在CSE的政策中定義）
對本新聞稿的充分性或準確性承擔責任。
SOURCE: AI/ML Innovations Inc.
來源：AI/ML Innovations Inc.
譯文內容由第三人軟體翻譯。